International Circulation: So you don’t think it would interfere with any of the guidelines for the treatment of heart failure?
《国际循环》:因此,您并不认为它将影响任何一个指南对心衰治疗的指导?
Prof. Nissen:I don’t think so. The guidelines now in the United States say ACE first, followed by ARBs as a
secondarychoice since they are useful. We don’t have quite as much of a problem with cough as there is in China, but I
can see how here having more options would be a good thing.
Nissen教授:我认为如此。美国指南认为首选ACE,其次为ARBs,因为他们更有效。我们并没有中国那么多咳嗽的患者,但是提供一种新选择总是很好的。
上一页 [1] [2] [3] [4] 下一页
网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆